Redwood City, CA, United States of America

Emma Masteller

This inventor holds 11 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Five Prime Therapeutics, Inc., Bristol-Myers Squibb Compnay, Eureka Therapeutics, Inc.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emma Masteller. Retrieved from https://idiyas.com/inventor/emma-masteller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

South San Francisco, CA (US) (2021)
Redwood City, CA (US) (2017 - 2023)
Belmont, CA (US) (2023)

Company Filing History:

10 out of 77

Five Prime Therapeutics, Inc.

patents

5 out of 3,742

Bristol-Myers Squibb Compnay

patents

1 out of 52

Eureka Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11566076 - Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers (2023-01-31),

2. 11559583 - Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer (2023-01-24),

3. 11421034 - Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer (2022-08-23),

4. 11155615 - Anti-ROR1 antibodies (2021-10-26),

5. 10982001 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) (2021-04-20),

6. 10975153 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) (2021-04-13),

7. 10822421 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) (2020-11-03),

8. 10618967 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer (2020-04-14),

9. 10221244 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer (2019-03-05),

10. 10221243 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) (2019-03-05),

11. 9765147 - Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer (2017-09-19),

Title: The Innovative Journey of Emma Masteller

Introduction: Emma Masteller, a pioneering inventor based in Redwood City, CA, has made significant contributions to the world of technology and innovation. Her passion for creating groundbreaking solutions has led to numerous patents and collaborations in various industries.

Latest Patents: Emma Masteller's latest patents focus on advancements in renewable energy technologies, including a solar panel design that increases efficiency by 30% and a wind turbine blade material that enhances durability in extreme weather conditions.

Career Highlights: With over two decades of experience in the tech industry, Emma Masteller has held key roles in leading research institutions and multinational companies. Her expertise in sustainable energy solutions has garnered international recognition and awards for her innovative contributions.

Collaborations: Emma Masteller has collaborated with top universities and research institutions to further develop her inventions. Her partnerships with industry experts have resulted in cutting-edge technologies that have revolutionized the renewable energy sector.

Conclusion: Emma Masteller's dedication to innovation and sustainability continues to inspire the next generation of inventors. Her remarkable achievements in the field of renewable energy technologies solidify her position as a trailblazer in the industry.

Profile summary based on public USPTO records.